ANTI-AGING MEDICINE IS A TREND IN MODERN RUSSIAN MEDICINE

Download full text PDF
Issue: 
6
Year: 
2016

Professor S. Trofimova (1), MD; A. Trofimov (2), MD; Professor A. Ilnitsky (3), MD; Professor K. Proshchaev (4), MD 1 -Saint Petersburg Institute of Bioregulation and Gerontology 2 -ZAO «Tree of Life. Clinic of Predictive Medicine», Saint Petersburg 3 -Institute of Advanced Training, Federal Biomedical Agency of Russia, Moscow 4 -Gerontology Research Medical Center, Moscow

The paper sets forth the main current views of a new area, such as anti-aging medicine, the implementation of effective individual programs for preventing the development and progression of chronic diseases and age-related conditions. It presents the used innovative diagnostic methods, as well as prevention and treatment programs based on peptidergic regulation.

Keywords: 
personalized medicine
anti-aging medicine
molecular genetic testing
biological age estimation
peptide bioregulators
decreased morbidity



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Anisimov V.N. Molekuljarnye i fiziologicheskie mehanizmy starenija. V 2 t. 2-e izd., pererab. i dop. / SPb: Nauka, 2008.
  2. Anisimov V.N. Melatonin i ego mesto v sovremennoj meditsine // RMZh. – 2006; 14 (4): 269–73.
  3. Anisimov V.N., Kvetnoj I.M., Komarov F.I. i dr. Melatonin v fizio logii i patologii zheludochno-kishechnogo trakta / M.: Sovetskij sport, 2000; 184 s.
  4. Il'nitskij A.N., Proschaev K.I. Nemnogo istorii i sovremennaja kontsep tsija geriatrii // Meditsinskaja sestra. – 2014; 5: 4–6.
  5. Il'nitskij A., Trofimova S., Belov D. i dr. Preventivnaja geriatrija kak novoe napravlenie v klinicheskoj praktike // Vrach. – 2015; 6: 29–31.
  6. Kvetnaja T.V., Knjaz'kin I.V., Kvetnoj I.M. Melatonin – nejroimmuno endokrinnyj marker vozrastnoj patologii / SPb: DEAN, 2005; s. 106–7.
  7. Morozov V.G., Havinson V.H. Novyj klass biologicheskih reguljatorov mnogokletochnyh sistem – tsitomediny // Uspehi sovremennoj biologii. – 1983; 96, Vyp. 3 (6): 339–52.
  8. Morozov V.G., Havinson V.H. Rol' kletochnyh mediatorov (tsitomedi nov) v reguljatsii geneticheskoj aktivnosti // Izvestija AN SSSR. Ser. «Biologija» – 1984; 4: 581–7.
  9. Ponomareva I.P. Sovremennaja strategija palliativnoj pomoschi v geriatrii // Meditsinskaja sestra. – 2015; 4: 4–7
  10. Prognoz dolgosrochnogo sotsial'no-ekonomicheskogo razvitija Rossijskoj Federatsii na period do 2030 goda / M.: Minekonomrazvitija RF, 2013.
  11. Trofimov A., Trofimova S. 15-letnij opyt primenenija molekuljarno geneticheskogo issledovanija v klinicheskoj praktike // Vrach. – 2015; 6: 66–8.
  12. Havinson V.H., Molekuljarnye osnovy peptidergicheskoj regljatsii starenija / SPb: Nauka, 2011; 174 s.
  13. Havinson V.H., Solov'ev A.Ju., Tarnovska S.I. i dr. Mehanizm biologi cheskoj aktivnosti korotkih peptidov: proniknovenie v kletku i epigenetiche-skaja reguljatsija ekspressii genov // Uspehi sovremennoj biologii. – 2013; 133 (2): 197–203.
  14. Damjanovic A., Yang Y., Glaser R. et al. Accelerated telomere erosion is . associated with a declining immune function of caregivers of Alzheimer's disease patients // J. Immunol. – 2007; 179 (6): 4249–54.
  15. Dardente H., Dardente H., Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals // Chronobiol. Intern. – 2007; 24 (2): 195–213.
  16. Fitzpatrick W., Lowry N. PLEDs: clinical correlates // Can. J. Neurol. Sci. – 2007; 34 (4): 443–50.
  17. Hoffmann J., Spyridopoulos I. Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging // Future Cardiol. – 2011; 7 (6): 789–803.
  18. Khavinson V., Malinin V. Gerontological Aspects of Genom Peptide Regulation / Basel (Switzerland): Karger AG, 2005; 104 p
  19. Kuznetsova T., Codd V., Brouilette S. et al. Association between left ventricular mass and telomere length in a population study // Am. J. Epidemiol. – 2010; 172 (4): 440–50.
  20. Njajou O., Cawthon R., Damcott C. et al. Telomere length is paternally inherited and is associated with parental lifespan // Proc. Natl. Acad. Sci. USA. – 2007; 104 (29): 12135–9.
  21. Takubo K., Izumiyama-Shimomura N., Honma N. et al. Telomere lengths are characteristic in each human individual // Exp. Gerontol. – 2002; 37: 523–31.
  22. Xiao F., Zheng X., Cui M. et al. Telomere dysfunction-related serological 22. markers are associated with type 2 diabetes // Diabetes Care. – 2011; 34 (10): 2273–8.